Burden of pricey hepatitis C drugs heaviest in eastern Europe

LONDON, May 31 (Reuters) - New hepatitis C drugs that can cure the liver-destroying disease are revolutionising treatment but their high price is a huge burden in some countries, particularly in central and eastern Europe, according to a new study.